TradingView
Hellodolly1
May 25, 2020 1:31 PM

Inovio Pharmaceuticals - Short term not only COVID Long

Inovio Pharmaceuticals, Inc.NASDAQ

Description

Next 45 days packed with potential catalysts -
Friday ASCO poster with REGN regarding 2nd Cohort 85% 12 Month OS, Glioblastoma GBM
Results from COVID animal challenge data on ferrets and monkeys, (mice and guinea pigs published last week),
CEPI funding announcement, WHO, GATTES?
COVID PHII announcements in Korea and China,
FDA Approval PHII U.S.,
Inclusion in Warp Speed announcement,
Prostate Trials - Parker Institute

Comments
azhark01
Thank you. Very useful. When do you think INO will announce the Phase 2 trial?
Hellodolly1
@azhark01, INO is having a webinar June 1, 2020 with all their big scientific guns working on INO-4800 (COVID) and the GBM trials with REGN. Go their website for todays announcement and registration for the webinar. This is a first and many rumors are circulating as to what this means??

PHII announcement will come after the PHI data and animal challenge studies. We've been checking with IR to see if they plan on announcing the animal challenge data (ferrets and primates) at the same time they announce the results from PhI human trials which are now wrapping up. Look for the PhI data mid - late June before the PHII announcement immediately following IMHO.
azhark01
@DavidEbby, thank you! MRNA down 15% today. What you think its good buy before market close today?
More